Detalhe da pesquisa
1.
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences.
BMC Health Serv Res
; 17(1): 74, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28114939
2.
Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation.
P T
; 38(2): 109-15, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23599678
3.
Modelling the potential long-term survival benefit of evinacumab treatment vs. standard of care in patients with homozygous familial hypercholesterolaemia.
Eur J Prev Cardiol
; 30(17): 1874-1880, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314419
4.
Rare coding variants in CHRNB2 reduce the likelihood of smoking.
Nat Genet
; 55(7): 1138-1148, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308787
5.
Diagnostic Value and Cost-Effectiveness of Next-Generation Sequencing-Based Testing for Treatment of Patients with Advanced/Metastatic Non-Squamous Non-Small-Cell Lung Cancer in the United States.
J Mol Diagn
; 24(8): 901-914, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688357
6.
Cost-effectiveness of tofacitinib compared with infliximab, adalimumab, golimumab, vedolizumab and ustekinumab for the treatment of moderate to severe ulcerative colitis in Germany.
J Med Econ
; 24(1): 279-290, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502905
7.
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada.
Pharmacoecon Open
; 3(3): 321-331, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617952
8.
An economic evaluation of tofacitinib for the treatment of moderately-to-severely active ulcerative colitis: modeling the cost of treatment strategies in the United States.
J Med Econ
; 22(9): 859-868, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012362
9.
Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada.
J Med Econ
; 19(6): 557-67, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26761644
10.
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence.
Clin Ther
; 38(3): 478-93.e1-16, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26922297
11.
Chemical and Synthetic Genetic Array Analysis Identifies Genes that Suppress Xylose Utilization and Fermentation in Saccharomyces cerevisiae.
G3 (Bethesda)
; 1(4): 247-58, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22384336
12.
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
Pharmacoeconomics
; 28(9): 751-64, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20623994
13.
Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder.
J Med Econ
; 12(4): 259-68, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19769548